NASDAQ:INBS

Intelligent Bio Solutions (INBS) Stock Price, News & Analysis

Intelligent Bio Solutions logo
$1.47 -0.07 (-4.55%)
As of 09:50 AM Eastern
This is a fair market value price provided by Massive. Learn more.

About Intelligent Bio Solutions Stock (NASDAQ:INBS)

Advanced

Key Stats

Today's Range
$1.45
▼
$1.46
50-Day Range
$1.44
▼
$2.29
52-Week Range
$1.35
▼
$24.90
Volume
5,620 shs
Average Volume
266,745 shs
Market Capitalization
$4.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Reduce

Company Overview

Intelligent Bio Solutions Inc. is a medical technology company focused on non-invasive testing and diagnostic solutions. Its flagship offering is the Intelligent Fingerprinting Drug Screening System, which analyzes trace sweat collected from a person’s fingertips to screen for drugs.

The system combines a portable reader with single-use fingerprint test cartridges. Its compact format is designed for use in settings such as workplaces, law enforcement, drug treatment and rehabilitation programs, and other organizations that conduct screening.

The company adopted its current name after acquiring UK-based Intelligent Fingerprinting in 2023. Its fingerprint testing technology is developed and commercialized through operations serving customers in multiple markets.

AI Generated. May Contain Errors.

Intelligent Bio Solutions Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
25th Percentile Overall Score

INBS MarketRank™: 
1.22526113249 of 5 stars

Intelligent Bio Solutions scored higher than 25% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Intelligent Bio Solutions has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    Intelligent Bio Solutions has only been the subject of 1 research reports in the past 90 days.

  • Read more about Intelligent Bio Solutions' stock forecast and price target.
  • Earnings Growth

    Earnings for Intelligent Bio Solutions are expected to grow in the coming year, from ($5.18) to ($4.06) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Intelligent Bio Solutions is -0.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Intelligent Bio Solutions is -0.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Intelligent Bio Solutions has a P/B Ratio of 0.68. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.97% of the float of Intelligent Bio Solutions has been sold short.
  • Short Interest Ratio / Days to Cover

    Intelligent Bio Solutions has a short interest ratio ("days to cover") of 3.08, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Intelligent Bio Solutions has recently decreased by 30.26%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Intelligent Bio Solutions does not currently pay a dividend.

  • Dividend Growth

    Intelligent Bio Solutions does not have a long track record of dividend growth.

  • News Sentiment

    Intelligent Bio Solutions has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • Insider Buying vs. Insider Selling

    In the past three months, Intelligent Bio Solutions insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    2.76% of the stock of Intelligent Bio Solutions is held by insiders.

  • Percentage Held by Institutions

    32.97% of the stock of Intelligent Bio Solutions is held by institutions.

  • Read more about Intelligent Bio Solutions' insider trading history.
Receive INBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

INBS Stock News Headlines

Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel
Intelligent Bio Solutions (INBS) Set to Announce Earnings on Wednesday
See More Headlines

INBS Stock Analysis - Frequently Asked Questions

Intelligent Bio Solutions' stock was trading at $9.53 on January 1st, 2026. Since then, INBS stock has decreased by 84.2% and is now trading at $1.51.

Intelligent Bio Solutions Inc. (NASDAQ:INBS) posted its earnings results on Tuesday, November, 10th. The company reported ($0.86) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.31) by $0.45. The company had revenue of $1.39 million for the quarter, compared to analysts' expectations of $1.40 million. Intelligent Bio Solutions had a negative trailing twelve-month return on equity of 150.00% and a negative net margin of 269.28%.

Shares of Intelligent Bio Solutions reverse split on the morning of Monday, January 29th 2024.The 1-12 reverse split was announced on Monday, January 29th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Intelligent Bio Solutions (INBS) raised $22 million in an IPO on Wednesday, December 23rd 2020. The company issued 1,270,589 shares at a price of $16.00-$18.00 per share.

Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Intelligent Bio Solutions investors own include NVIDIA (NVDA), Quantum Computing (QUBT), SNDL (SNDL), Energy Fuels (UUUU), Energy Transfer (ET), Salesforce (CRM) and Aeva Technologies (AEVA).

Company Calendar

Last Earnings
11/10/2026
Today
11/20/2026
Fiscal Year End
6/30/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:INBS
Previous Symbol
NASDAQ:GBS
CIK
1725430
Fax
N/A
Employees
60
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($6.38)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.43 million
Net Margins
-269.28%
Pretax Margin
-270.06%
Return on Equity
-150.00%
Return on Assets
-83.38%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.98
Quick Ratio
1.87

Sales & Book Value

Annual Sales
$4.22 million
Price / Sales
1.15
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.22 per share
Price / Book
0.66

Miscellaneous

Outstanding Shares
3,320,000
Free Float
3,225,000
Market Cap
$4.87 million
Optionable
Not Optionable
Beta
4.48
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NASDAQ:INBS) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners